Innovative Biomaterials Synergize Oncolytic Virus for Elevating Tumor Immunotherapy Potency
Advanced Materials · 2026
DOI: 10.1002/adma.202519222 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Materials, 2026. Verfasst von Jiaxue Wen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Luminescence Analysis and Molecular Sensing, Ministry of Education, School of Materials and Energy, College of Sericulture, Textile…. Hauptthemen laut MEDLINE: Oncolytic Viruses, Immunotherapy, Biocompatible Materials, Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 228 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities, Chongqing Natural Science Foundation.
Abstract (Originalsprache)
Cancer immunotherapy, particularly using oncolytic viruses (OVs), has been recognized as a promising approach for treating malignant tumors because of its dual ability to selectively kill tumor cells and activate antitumor immunity. However, OV monotherapy faces inherent challenges, including suboptimal viral delivery efficiency, an immunosuppressive tumor microenvironment, and premature systemic‐immune clearance. Recent breakthroughs in biomaterials have provided new avenues for optimizing oncolytic virotherapy by overcoming these limitations using innovative system designs. In this review, we systematically examined the synergistic combination of biomaterials with OVs to enhance cancer immunotherapy, emphasizing two major categories: nanomaterial‐based carriers and cell‐derived materials. Intelligent biomaterial delivery systems can spatiotemporally protect viruses from immune clearance and enable targeted accumulation and controlled release. Functionalized biomaterials can serve as immunomodulators or drug carriers that synergize with OVs to remodel the tumor microenvironment. Particular focus was placed on biomimetic virus‐like nanoparticles, and their design principles, mechanisms, and applications were critically discussed in this review. Finally, we summarize the potential challenges and prospects of combining biomaterials with OVs to enhance cancer immunotherapy, paving the way for a clinical translation of this approach.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Luminescence Analysis and Molecular Sensing, Ministry of Education, School of Materials and Energy, College of Sericulture, Textile and Biomass Sciences, Southwest University, Chongqing, China.
- State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School & Hospital of Stomatology, Frontier Sci…
ORCID-Profile: Zhi-Jun Sun, Zhigang Xu
Förderung
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central Universities
- Chongqing Natural Science Foundation
- Chongqing Engineering Research Center for Micro-Nano Biomedical Materials and Devices
Zitieren
APA
Wen, J., Li, S. J., Xiao, R., Shi, X., Sun, Z. J., & Xu, Z. (2026). Innovative Biomaterials Synergize Oncolytic Virus for Elevating Tumor Immunotherapy Potency. Advanced Materials. https://doi.org/10.1002/adma.202519222
Vancouver
Wen J, Li SJ, Xiao R, Shi X, Sun ZJ, Xu Z. Innovative Biomaterials Synergize Oncolytic Virus for Elevating Tumor Immunotherapy Potency. Advanced Materials. 2026. doi:10.1002/adma.202519222
BibTeX
@article{Wen2026,
author = {Wen, Jiaxue and Li, Shu-Jin and Xiao, Ruohan and Shi, Xiaoxiao and Sun, Zhi-Jun and Xu, Zhigang},
title = {Innovative Biomaterials Synergize Oncolytic Virus for Elevating Tumor Immunotherapy Potency},
journal = {Advanced Materials},
year = {2026},
doi = {10.1002/adma.202519222}
}
EUVIMED